On Wednesday, Merge Healthcare Inc. (NASDAQ:MRGE)’s shares declined -9.43% to $4.80.
Merge Healthcare Inc. (MRGE) disclosed its financial and business results for the first quarter of 2015.
Justin Dearborn, chief executive officer of Merge Healthcare stated that Merge achieved strong sales momentum in the first quarter of the year in spite of a traditionally slow time of the year and the acquisition of D.R. Systems, Inc. in the quarter. Exclusive of the limited contribution from D.R. Systems, our healthcare segment bookings increased 60% over the first quarter of 2014. Their sales results were heavily influenced by increased traction in their large hospital system installed base and a few large net new hospital wins. Increased contract volume within their hospital market and cross sell opportunities into their newly acquired D.R. Systems installed base of more than 200 clients give us confidence that they can exceed revenue of $248 million, which aligns with their current covering analysts’ 2015 average revenue estimates.
Merge Healthcare Incorporated develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians worldwide.
Denny’s Corporation (NASDAQ:DENN)’s shares dropped -8.87% to $10.69.
Denny’s Corporation (DENN) plans to declare financial and operating results for its first quarter ended April 1, 2015 on Monday, May 4, 2015, after the markets close. Senior administration will hold a conference call on the same day at 4:30 p.m. (ET) to talk about these results and answer questions.
Danny’s Corporation, through its partner, Danny’s, Inc., owns and operates full-service restaurants under the Danny’s brand name. As of December 31, 2014, it operated 1,702 franchised, licensed, and company owned restaurants, counting 1,596 restaurants in the United States; and 106 restaurants in Canada, Costa Rica, Mexico, Honduras, Guam, Curaçao, Puerto Rico, Dominican Republic, El Salvador, Chile, and New Zealand.
At the end of Wednesday’s trade, Aerie Pharmaceuticals Inc (NASDAQ:AERI)‘s shares dipped -8.36% to $10.08.
Aerie Pharmaceuticals Inc (AERI) declared that its first quarter 2015 financial results will be released after the market closes on Thursday, May 7, 2015. Following the release, the Company will host a live conference call and webcast at 5:00 p.m. Eastern Time to talk about the Company’s financial results and provide a general business and planned update. Additionally, the Company has been ongoing to review the results of its first Phase 3 registration trial (“Rocket 1”) for Rhopressa™ and anticipates to talk about additional findings from the Rocket 1 study during the live conference call and webcast.
Aerie Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of first-in-class therapies for the treatment of glaucoma and other eye diseases.
Etsy Inc (NASDAQ:ETSY), ended its Wednesday’s trading session with -8.45% loss, and closed at $22.42.
Etsy Inc (ETSY) declared the closing of its initial public offering and the exercise in full of the underwriters’ option to purchase an additional 2,499,999 shares from selling stockholders.
After the underwriters’ exercise of the option to purchase additional shares, a total of 19,166,665 shares were sold at the price to the public of $16.00 per share for a total of $306,666,640 in aggregate gross proceeds, which comprised of the sale of 5,833,332 shares by selling stockholders. Etsy will not receive any proceeds from the sale of shares by the selling stockholders.
Etsy, Inc. operates online and offline marketplaces to buy and sell handmade items, vintage goods, and craft supplies. Its platform connects sellers and buyers to sell or buy products for art, home and living, mobile accessories, jewelry, wedding, and others.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
